Drugs / Budesonide MMX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05341401 Comparator | Jun 2022 → Jun 2023 | ulcerative colitis | Assiut University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Budesonide MMX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05341401 ↗ |
| Modality | Small molecule | “Budesonide MMX is a second generator corticosteroid with prolonged colonic release used for management of ulcerative colitis” NCT05341401 ↗ |